Exclusive and Patented Technology

Cordlife is the only stem cell bank in the Philippines that provides total stem cell banking solution for your family’s complete protection against potential diseases. Unlike conventional technology, Cordlife’s Cell Optima^™ technology can harvest two other potentially useful stem cells from the umbilical cord lining: mesenchymal and epithelial stem cells. This patented technology is exclusively available at Cordlife.

More than 20 years ago, bone marrow was found to contain MSCs. Subsequently, scientists also found that Wharton’s Jelly from the umbilical cord contain MSCs as well. More recently, a team of award-winning doctor and scientist from Singapore made significant inroad in the world with the discovery of two powerful stem cell types, MSCs and EpSCs, from cord lining. Together, the Cambridge and Stanford University trained duo developed a unique technology known as CellOptima^™, designed to harvest and multiply stem cells from cord lining. This revolutionary discovery subsequently led the team to receive more than 40 patent grants from 40 countries including United States, Europe, China, Singapore and Hong Kong. These patents prohibit anybody other than the patent owner from harvesting stem cells from cord lining.

What makes CellOptima^™ special?

CellOptima^™ is an original invention from Singapore. Patent protection of CellOptima^™ has been granted by many countries because the technology is novel, first-of-its-kind and useful. All patents granted for CellOptima^™ prevents other companies from harvesting stem cells from cord lining.